Shareholders that lost money on MacroGenics, Inc. should contact Levi Korsinsky about Securities Fraud Investigation - MGNX

MGNX Stock  USD 3.50  0.11  3.24%   
Slightly above 58% of all MacroGenics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding MacroGenics suggests that some traders are interested. MacroGenics' investing sentiment can be driven by a variety of factors including economic data, MacroGenics' earnings reports, geopolitical events, and overall market trends.
  
NEW YORK, NY ACCESSWIRE July 17, 2024 Levi Korsinsky notifies investors that it has commenced an investigation of MacroGenics, Inc. concerning possible viol

Read at accesswire.com
news
  

MacroGenics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards MacroGenics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

MacroGenics Fundamental Analysis

We analyze MacroGenics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MacroGenics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MacroGenics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

MacroGenics is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

MacroGenics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MacroGenics stock to make a market-neutral strategy. Peer analysis of MacroGenics could also be used in its relative valuation, which is a method of valuing MacroGenics by comparing valuation metrics with similar companies.

Peers

MacroGenics Related Equities

CCCCC4 Therapeutics   13.33   
0%
100.0%
GLUEMonte Rosa   6.57   
0%
49.0%
IPSCCentury Therapeutics   6.29   
0%
47.0%
CGEMCullinan Oncology   4.98   
0%
37.0%
ZNTLZentalis Pharmaceuticals   4.79   
0%
35.0%
TYRATyra Biosciences   3.69   
0%
27.0%
INZYInozyme Pharma   3.63   
0%
27.0%
EWTXEdgewise Therapeutics   3.23   
0%
24.0%
DAWNDay One   2.15   
0%
16.0%
PEPGPepGen   1.42   
0%
10.0%
SNDXSyndax Pharmaceuticals   1.25   
0%
9.0%
PTGXProtagonist Therapeutics   0.91   
0%
6.0%
MLYSMineralys Therapeutics,   0.00   
0%
0%
PMVPPmv Pharmaceuticals   0.00   
0%
0%
ANTXAN2 Therapeutics   0.69   
5.0%
0%
MOLNMolecular Partners   1.55   
11.0%
0%
KZRKezar Life   2.16   
16.0%
0%
PHVSPharvaris   2.25   
16.0%
0%
NKTXNkarta   2.27   
17.0%
0%

Additional Tools for MacroGenics Stock Analysis

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.